In recent years, more women are getting married and starting a family at an older age.Advanced maternal age (AMA) is defined as age 35 years or more for the mother. This group has beenobserved to have a high risk of chromosomal abnormalities in their embryos during pregnancy becausethe quality of oocytes correlate with maternal age and corresponding reproductive clinical outcomes (1).In 2013, Harton et al. reported that higher maternal age appears to be associated with increased risk ofaneuploidy in embryos :<35 yrs (53.1%), 35-37 yrs (68.2%), 38-40 yrs (73.7%), 41-42 yrs (85.8%), >42 yrs(92.6%) from 451 blastomeres and <35 yrs (31.7%), 35-37 yrs (44.2%), 38-40 yrs (43.1%), 41-42 yrs(76.3%), >42 yrs (84.8%) from 462 blastocysts (2). Moreover, Menken et al. reported on the effects ofmaternal age on fertility with a decrease in birth rates when maternal age is >/= 35 yrs(3). For thisreason, assisted reproductive technology (ART) and preimplantation genetic screening (PGS)can be helpto infertile couples and patients at high risk of there being chromosome abnormalities in the embryo. PGSis the technology used for screening chromosome abnormalities to selectively transfer euploid embryos inIVF. Patients using PGS have a higher implantation rate and pregnancy rate compared to those usingmorphological assessment ofembryos alone (4–10).